Infliximab for Injection
Efficacy and safety are equivalent to the original drug (Johnson & Johnson/Merck & Co.
The first infliximab biosimilar marketed in China
Infliximab for Injection (Reminton), a recombinant anti-TNF-alpha chimeric monoclonal antibody, was approved for marketing by the National Medical Products Administration (NMPA) on July 14, 2021. It is the first infliximab biosimilar marketed in China. Taking advantage of CHO cell expression system, Remin_x005f ton has been proved with good efficacy, better safety, and lower immunogenicity in clinical studies.
Indications:
Crohn's disease in adults and children over 6 years of age, stulizing Crohn's disease,
ulcerative colitis in adults, ankylosing spondylitis, rheumatoid arthritis, and psoriasis.
Recommended reading
Related products
-
Quick View
Pellentesque dignissim sapien semper
$78.00Add to cartCras luctus ultricies ex luctus malesuada. Fusce imperdiet interdum consectetur. Pellentesque dignissim sapien semper consequat sollicitudin. Phasellus iaculis libero ac placerat aliquam. Etiam a velit eu diam consequat vestibulum. Ut a malesuada nulla. Vivamus quis maximus nisi, vel molestie sapien. Nunc pharetra finibus elit sed consectetur.
-
Quick View
The Benefits of Roof Insulation: Is it a Wise Investment?
Read moreRoof insulation is a topic that often goes unnoticed, yet it plays a crucial role in maintaining a comfortable and energy-efficient home. Many homeowners wonder whether insulating their roof is a good idea. In this article, we will delve into the benefits of roof insulation, exploring its impact on energy efficiency, cost savings, and overall …
The Benefits of Roof Insulation: Is it a Wise Investment?Read More
-
Quick View
Nulla feugiat felis tempor sem
$61.00Add to carteget ullamcorper leo auctor. Donec at interdum nibh, in blandit massa. Nam pulvinar mollis quam, vel fringilla mi interdum elementum. Donec ullamcorper turpis et libero sagittis vestibulum. Donec enim nisl, rhoncus vitae magna eu, convallis tempus tortor. Integer et facilisis metus.
-
Quick View
Aliquam id quam elementum arcu eleifend
$44.00Add to cartAenean bibendum posuere neque, quis hendrerit libero ultrices lacinia. Vestibulum venenatis elit non bibendum pulvinar. In luctus urna sapien, posuere fermentum nunc tempus eget. Fusce hendrerit nec diam quis ornare. Duis auctor, libero in efficitur finibus, purus diam maximus est, et rhoncus sapien justo nec sem
Reviews
There are no reviews yet.